David Happel - 07 Dec 2023 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
President & CEO, Director
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
Issuer symbol
SGMT
Transactions as of
07 Dec 2023
Net transactions value
+$6,560
Form type
4
Filing time
08 Dec 2023, 16:05:24 UTC
Previous filing
21 Nov 2023
Next filing
28 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGMT Series A Common Stock Purchase $6,560 +1,600 +0.26% $4.10 627,100 07 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price. The shares were purchased in multiple transactions at prices ranging from $4.02 per share to $4.16 per share. The Reporting Person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each price.